Kaitlyn Beverly, PA
Medical · Conway, SCNPI 1255974655
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Sanofi at 37.5% of the total. Reporting peaked in 2023 at $161 and has fallen 58.5% since, to $67 in 2025. That places this record below the midpoint for medical clinicians in SC, where the typical reported total is $906.
Across 13 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$111
- GSK$76
- Stryker$32
- Phathom Pharmaceuticals, Inc.$28
- Optinose US, Inc.$19
- Olympus America Inc.$15
- plus $14 from 1 others
What the payments were for
- Food & beverage$295100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 3 | $111 |
| GSK | 4 | $76 |
| Stryker | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Optinose US, Inc. | 1 | $19 |
| Olympus America Inc. | 1 | $15 |
| Merck | 1 | $14 |
How this compares
$295 in reported general payments places this provider in the 30th percentile of 384 medical providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 253 | $5,388 |
| Ipratropium Bromide | 122 | $4,337 |
| Mometasone Furoate | 31 | $2,610 |
| Fluocinolone Acetonide Oil | 29 | $1,629 |
| Dexamethasone Sodium Phosphate | 21 | $1,447 |
| Omeprazole | 135 | $936 |
| Azelastine Hcl | 35 | $774 |
| Famotidine | 75 | $705 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 15 | $699 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 42 | $561 |
| Prednisone | 68 | $520 |
| Cefdinir | 30 | $485 |
| Montelukast Sodium | 64 | $469 |
| Doxycycline Hyclate | 32 | $443 |
| Levocetirizine Dihydrochloride | 23 | $340 |
Paid to pharmacies, not to this prescriber.
Other medical in Conway
- Christopher ThompsonSpartanburg$78K
- Laura BuchGreenville$73K
- Suzanne SmithWest Columbia$39K
- Stavros ChrysostomidesColumbia$39K
- Ethan CaseySpartanburg$24K
- Jessica HallColumbia$22K
- Mary MacdonaldCharleston$20K
- Cameron PappasGreenville$18K
- Leslie RumbautGrenville$18K
- Claire DukeGreenville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.